Incannex Healthcare Limited (IXHL) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
IXHL Revenue Growth
IXHL Revenue Analysis (2014–2025)
As of May 8, 2026, Incannex Healthcare Limited (IXHL) generated trailing twelve-month (TTM) revenue of $103,965, reflecting explosive growth of +270.8% year-over-year. The most recent quarter (Q4 2025) recorded $66,616 in revenue, up 243.7% sequentially.
Looking at the longer-term picture, IXHL's 5-year compound annual growth rate (CAGR) stands at -27.0%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $1.4 million in 2021.
When compared to Healthcare sector peers including ATAI (+811.8% YoY), and LWAY (+13.7% YoY), IXHL has underperformed the peer group in terms of revenue growth. Compare IXHL vs ATAI →
IXHL Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| IXHLCurrent | $103,965 | +270.8% | -27.0% | -27661.6% | |
 ATAI | $308,000 | +811.8% | - | -33341.2% | |
 LWAY | $212M | +13.7% | +15.8% | 7.6% |
IXHL Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $86K | +378.7% | $86K | 100.0% | $-23,789,000 | -27661.6% |
| 2024 | $18K | - | $18K | 100.0% | $-44,974,381 | -250341.7% |
| 2023 | $0 | - | $0 | - | $-13,638,000 | - |
| 2022 | $0 | -100.0% | $-4,359 | - | $-10,164,241 | - |
| 2021 | $1.4M | +243.0% | $741K | 51.9% | $-8,573,546 | -601.3% |
| 2020 | $416K | -49.6% | $106K | 25.5% | $-2,849,111 | -685.5% |
| 2019 | $825K | +11.0% | $418K | 50.6% | $-1,952,608 | -236.6% |
| 2018 | $744K | +243.1% | $359K | 48.2% | $-2,363,931 | -317.9% |
| 2017 | $217K | - | $-180,166 | -83.1% | $-16,103,412 | -7429.9% |
| 2016 | $0 | - | $0 | - | $-577,219 | - |
See IXHL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IXHL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IXHL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIXHL — Frequently Asked Questions
Quick answers to the most common questions about buying IXHL stock.
Is IXHL's revenue growth accelerating or slowing?
IXHL revenue is accelerating at +270.8% year-over-year, exceeding the 5-year CAGR of -27.0%. TTM revenue reached $103965.00. Growth momentum has increased versus prior periods.
What is IXHL's long-term revenue growth rate?
Incannex Healthcare Limited's 5-year revenue CAGR of -27.0% reflects the sustained expansion pattern. Current YoY growth of +270.8% is above this long-term average.
How is IXHL's revenue distributed by segment?
IXHL reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.